Suchergebnisse - "Coates, Emily E"

PubPharm (41)

1

Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LS

enthalten in: JCI insight | 2024

von Awan, S. | Pegu, A. | Strom, L. | +34

2

Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials

enthalten in: NPJ vaccines | 2024

von Happe, M. | Hofstetter, A. | Wang, J. | +95

3

HIV vaccines induce CD8+ T cells with low antigen receptor sensitivity

enthalten in: Science (New York, N.Y.) | 2023

von Migueles, S. | Nettere, D. | Gavil, N. | +38

4

Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults : a phase 1, open-label, dose-escalation clinical trial

enthalten in: The Lancet. Infectious diseases | 2023

von Mwesigwa, B. | Houser, K. | Hofstetter, A. | +73

ErratumIn: Lancet Infect Dis. 2023 Oct;23(10):e400. - PMID 37652067

5

Chikungunya virus virus-like particle vaccine is well tolerated and immunogenic in chikungunya seropositive individuals

enthalten in: Vaccine | 2023

von McCarty, J. | Bedell, L. | Mendy, J. | +6

6

Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C) : a phase 1, adaptive trial

enthalten in: The Lancet. Infectious diseases | 2023

von Lyke, K. | Berry, A. | Mason, K. | +98

CommentIn: Lancet Infect Dis. 2023 May;23(5):514-516. - PMID 36708739

7

An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults

enthalten in: Science translational medicine | 2023

von Widge, A. | Hofstetter, A. | Houser, K. | +123

8

Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA : a first-in-human, phase 1, open-label, dose-escalation trial

enthalten in: Lancet (London, England) | 2023

von Hamer, M. | Houser, K. | Hofstetter, A. | +53

CommentIn: Lancet. 2023 Jan 28;401(10373):251-253. - PMID 36709065

9

Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses : a phase 1, open-label, dose-escalation, randomised clinical trial

enthalten in: The Lancet. Infectious diseases | 2022

von Coates, E. | Edupuganti, S. | Chen, G. | +70

CommentIn: Lancet Infect Dis. 2022 Aug;22(8):1100-1102. - PMID 35568050

10

Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria

enthalten in: The New England journal of medicine | 2022

von Wu, R. | Idris, A. | Berkowitz, N. | +127

CommentIn: N Engl J Med. 2022 Aug 4;387(5):460-461. - PMID 35921456

1
2
3
4
5
Nächster »
[5]